HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Oral Care Tops Colgate Priorities, Ad Spending Grows With Marketplace 'Uncertainty'

This article was originally published in The Rose Sheet

Executive Summary

Colgate will boost its ad and promotional spend in 2017 “quite meaningfully” from 2016 to track with competitors' levels. "We focus in order of priority behind oral care, pet nutrition, personal care, and home care," says CEO Ian Cook.

You may also be interested in...



Colgate Engages Consumers To 'Buy Into' Brands On Digital Spend Boost

Colgate targets at least 20% of its global media spending digitally as part of a larger marketing push to help counter marketplace uncertainties. It also is engaging in programs that create “meaning” for its brands and is engaging with consumers more on social media, says President and CEO Ian Cook.

P&G Looks To Follow Brand Trimming By Spreading Through M&A

P&G posts 2% organic growth in its latest quarter and its adjusted EPS beat analyst expectations as it is again interested in M&A. However, analysts ask whether P&G, under pressure from an activist investor, has entered a growth era or is pushing a “false positive.”

Activist Investor 'Buzz' Annoys Colgate CEO As Earnings Sting Shareholders

Colgate CEO Ian Cook says speculation that recent organic sales misses and competitive pressure make company an activist investor target is “noise” and the firm will combat competitive pressure through increasing advertising, growing e-commerce and expanding its natural product lines.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109055

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel